BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Business

  Abivax presents first-half 2024 financial results

  September 9, 2024

   · 

  9 min read
• Business

  TriArm Therapeutics Appoints Douglas E. Williams, Ph.D., as Chief Executive Officer

  September 9, 2024

   · 

  3 min read
• Business

  BioNxt Receives Positive International Examination Report From the European Patent Office for Broad Patent Application for Sublingual Delivery of Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases

  September 9, 2024

   · 

  4 min read
• Drug Development

  MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND

  September 9, 2024

   · 

  4 min read
• Business

  Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference

  September 9, 2024

   · 

  1 min read
• FDA

  ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)

  September 9, 2024

   · 

  6 min read
• Business

  Medline to launch MIS Foot Recon System at AOFAS 2024 Annual Scientific Conference

  September 9, 2024

   · 

  3 min read
• Drug Development

  Innovent Delivers Oral Presentation of Updated Results from a Pivotal Phase 2 Study of Dupert® (Fulzerasib) in Patients with Advanced Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation

  September 9, 2024

   · 

  6 min read